Institutional Career Development Core

联系PD/PI：Buchanan，Thomas A Inst-Career-Dev-001(724) 机构职业发展 项目摘要/摘要 南加州临床翻译学院个人职业发展(ICD)计划 在南加州大学和洛杉矶儿童医院内运作。我们的业务是在 在洛杉矶的心脏地带，85%的居民来自代表不足的少数族裔群体，20%的人生活在 联邦贫困水平，30%的人年龄在18岁以下，57%的成年人没有完成高中学业。这种病 负担很高，与贫困、犯罪、语言障碍和文化有关的健康差距放大了负担 信仰。因此，我们的目标是：1)培养进行严谨和可重复的临床翻译的领导者 研究(CTR)，识别并克服翻译障碍，以改善不同群体的健康 人口，2)赋予学者以维持CTR职业生涯，以及3)增加学者多样性，以更有效地 满足我们不同社区的健康需求。基于这些目标，我们对ICD制度进行了扩展 拥有最先进的教育和导师资源中心以及咨询和教师委员会的生态系统 具有强大的教育CTR专业知识和更广泛的URM代表。我们计划培训4名新学者 每年三年，通过国家卫生研究院、机构和部门基金。ICD计划建立在 成功的三门课程系列，强调CTR研究方法、严谨性和重复性，团队 不同人群的科学、沟通技能和研究，与全面的职业生涯相结合 发展计划。学者注册临床、生物医学和医学硕士或证书课程 翻译调查。新的ICD培训机会包括医疗保健提供科学、健康数据 科学、精准医学和设计品质。一个强大的远程教育平台已经到位， 记录、存档和传播教育材料；它还支持学者发展口语 交流技巧和传播他们的研究成果。体验机会包括与SC的互动 CTSI的核心专家，例如，数字招聘、社区参与、监管知识、社区 导师，以及在其他CTSA机构的访问学者研究报告。学者-导师团队使用 个人发展计划在整个计划中指导职业发展。职业生涯的障碍 进步是通过一个新的障碍缓解委员会确定和解决的，该委员会向学者们提供 对长期事业成功的适应力。我们创建了强大的跟踪和评估流程，为 并推进这一计划。数据显示ICD学者带来的变革性和广泛的制度变革 和校友过渡到独立的研究生涯，拥有雄厚的研究资金，学术生产力， 和进步。更广泛地说，我们在区域和国家范围内为培训和职业生涯做出了贡献。 通过在CTSA委员会和工作中分享工具和最佳实践以及领导，在CTR方面进行发展 组。我们期待着在下一个筹资周期扩大这一成功。

Contact PD/PI: Buchanan, Thomas A Inst-Career-Dev-001 (724) INSTITUTIONAL CAREER DEVELOPMENT Project Summary/Abstract The Southern California Clinical Translational Institute's Individual Career Development (ICD) Program operates within the University of Southern California and Children's Hospital Los Angeles. We operate in the heart of Los Angeles, where 85% of residents are from underrepresented minority groups, 20% live below the federal poverty level, 30% are under 18 years old, and 57% of adults do not complete high school. The disease burden is high and amplified by health disparities linked to poverty, crime, language barriers, and cultural beliefs. Thus, we aim to: 1) develop leaders who conduct rigorous and reproducible clinical translational research (CTR) that identifies and overcomes translational barriers to improve the health of diverse populations, 2) empower Scholars to sustain CTR careers, and 3) increase Scholar diversity to more effectively address our diverse communities' health needs. Based on these aims, we expand the ICD Institutional Ecosystem with state-of-the-art Education and Mentor Resource Centers and Advisory and Faculty Boards with strong educational CTR expertise and broader URM representation. We propose to train 4 new Scholars per year for three years each through NIH, institutional, and departmental funds. The ICD Program builds on a successful three-course series emphasizing CTR research methodology, rigor and reproducibility, team science, communication skills, and research in diverse populations, combined with a comprehensive career development program. Scholars enroll in a Master's or Certificate program in Clinical, Biomedical, and Translational Investigations. New ICD training opportunities include healthcare delivery science, health data science, precision medicine, and Quality by Design. A robust distance education platform is in place for recording, archiving, and disseminating educational materials; it also supports Scholars in developing oral communication skills and disseminating their research. Experiential opportunities include interactions with SC CTSI core experts in, e.g., digital recruitment, community engagement, regulatory knowledge, community mentors, and visiting scholar research presentations at other CTSA institutions. Scholars-Mentor teams use Individual Development Plans to guide career progression throughout the program. Barriers to career progression are identified and addressed through a novel Barriers Mitigation Board which informs scholars' resilience for long-term career success. We have created robust tracking and evaluation processes that inform and advance the program. Data show transformative and widespread institutional change due to ICD Scholars and alumni transitioning to independent research careers with robust research funding, academic productivity, and advancement. More broadly, we have contributed regionally and nationally to training and career development in CTR by sharing tools and best practices and leadership in CTSA committees and working groups. We look forward to expanding this success in the next funding cycle.